Kyndryl
KD
11.45
-0.03
-0.26%
Kyndryl
US · KD
#2612 by market cap
Listed 1970
11.45
-0.03
-0.26%
Live - 5344 symbols - heartbeat 78s ago
· 2026-10-08 05:39
Pre-market
11.50
+0.44%
After-hours
11.40
-0.44%
Overnight
11.63
+1.57%
- Market cap
- 2.49B
- P/E (TTM)i
- 30.95
- P/Bi
- 2.33
- EPSi
- 0.85
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on KD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.22, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.23% YoY
Margins
- Gross margin
- 21.79%
- Operating margin
- 4.21%
- Net margin
- 1.31%
Key ratios & quality
- Enterprise valuei
- 4.23B
- Altman Z-Scorei
- 1.22
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.28B | 19.35B | 18.66B | 4.43B | 17.03B | 16.05B | 15.06B | 15.09B |
| Gross profit | 2.60B | 2.22B | 2.11B | 607.00M | 2.53B | 2.86B | 3.14B | 3.29B |
| Selling & admin expenses | 2.97B | 2.95B | 2.78B | 690.00M | 2.91B | 2.77B | 2.59B | 2.65B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -373.00M | -733.00M | -669.00M | -83.00M | -386.00M | 90.00M | 552.00M | 635.00M |
| Pretax profit | -579.00M | -1.76B | -1.90B | -189.00M | -851.00M | -168.00M | 435.00M | 414.00M |
| Tax | 364.00M | 247.00M | 402.00M | 40.00M | 524.00M | 172.00M | 184.00M | 215.00M |
| Net profit | -943.00M | -2.01B | -2.31B | -229.00M | -1.38B | -340.00M | 251.00M | 199.00M |
| Basic EPS | -4 | -9 | -10 | -1 | -6 | -1 | 1 | 1 |
| Diluted EPS | -4.21 | -8.96 | -10.28 | -1.02 | -6.06 | -1.48 | 1.05 | 0.85 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.80B | 3.74B | 3.72B | 3.86B | 3.77B | 3.62B |
| Gross profit | 825.00M | 796.00M | 801.00M | 843.00M | 849.00M | 776.00M |
| Selling & admin expenses | 640.00M | 646.00M | 659.00M | 672.00M | 678.00M | 668.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 185.00M | 150.00M | 142.00M | 171.00M | 171.00M | 108.00M |
| Pretax profit | 118.00M | 92.00M | 98.00M | 91.00M | 133.00M | -69.00M |
| Tax | 50.00M | 36.00M | 30.00M | 34.00M | 115.00M | -14.00M |
| Net profit | 68.00M | 56.00M | 68.00M | 57.00M | 18.00M | -55.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.28 | 0.23 | 0.29 | 0.25 | 0.08 | -0.25 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.15B | 2.84B | 5.78B | 6.09B | 4.96B | 4.75B | 4.59B | 5.53B |
| Cash & ST investments | 36.00M | 24.00M | 2.22B | 2.13B | 1.85B | 1.55B | 1.79B | 2.62B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 11.74B | 11.21B | 13.21B | 13.44B | 11.46B | 10.59B | 10.45B | 12.55B |
| Total current liabilities | 3.41B | 3.91B | 4.46B | 5.06B | 4.87B | 4.59B | 4.30B | 6.31B |
| Short-term debt | 370.00M | 402.00M | 465.00M | 470.00M | 426.00M | 411.00M | 403.00M | 2.06B |
| Long-term debt | -- | 140.00M | 3.13B | 3.13B | 3.11B | 3.11B | 3.04B | 2.29B |
| Total liabilities | 5,796,000,000.00 | 6,275,000,000.00 | 10,445,000,000.00 | 10,730,000,000.00 | 10,002,000,000.00 | 9,468,000,000.00 | 9,120,000,000.00 | 11,259,000,000.00 |
| Total equity | 5.95B | 4.93B | 2.77B | 2.71B | 1.46B | 1.12B | 1.33B | 1.29B |
| Retained earnings | -- | 0 | -375.00M | -605.00M | -1.98B | -2.32B | -2.07B | -1.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.59B | 4.47B | 4.29B | 4.33B | 5.53B | 5.07B |
| Cash & ST investments | 1.79B | 1.46B | 1.33B | 1.35B | 2.62B | 2.10B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 10.45B | 11.50B | 11.24B | 11.28B | 12.55B | 12.03B |
| Total current liabilities | 4.30B | 4.24B | 4.20B | 5.04B | 6.31B | 5.98B |
| Short-term debt | 403.00M | 417.00M | 415.00M | 1.09B | 2.06B | 2.05B |
| Long-term debt | 3.04B | 3.01B | 3.00B | 2.30B | 2.29B | 2.29B |
| Total liabilities | 9,120,000,000.00 | 10,151,000,000.00 | 9,905,000,000.00 | 9,967,000,000.00 | 11,259,000,000.00 | 10,859,000,000.00 |
| Total equity | 1.33B | 1.34B | 1.34B | 1.31B | 1.29B | 1.17B |
| Retained earnings | -2.07B | -2.01B | -1.94B | -1.89B | -1.87B | -1.92B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.13B | 628.00M | -119.00M | 189.00M | 781.00M | 454.00M | 942.00M | 948.00M |
| Depreciation & amortization | 1.93B | 1.90B | 1.66B | 356.00M | 1.37B | 1.18B | 1.02B | 1.08B |
| Free cash flow | -56.00M | -408.00M | -871.00M | 9.00M | -84.00M | -197.00M | 337.00M | 340.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -1.00M | -3.00M | -19.00M | -22.00M | -138.00M | -398.00M |
| Ending cash balance | 50.00M | 38.00M | 2.24B | 2.15B | 1.86B | 1.55B | 1.79B | 2.63B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 581.00M | -124.00M | 146.00M | 428.00M | 498.00M | -310.00M |
| Depreciation & amortization | 303.00M | 271.00M | 274.00M | 274.00M | 259.00M | 257.00M |
| Free cash flow | 341.00M | -267.00M | 17.00M | 208.00M | 382.00M | -459.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -76.00M | -129.00M | -111.00M | -103.00M | -55.00M | -77.00M |
| Ending cash balance | 1.79B | 1.47B | 1.34B | 1.35B | 2.63B | 2.11B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -16.00 | -37.37 | -61.26 | -- | -69.01 | -28.57 | 22.56 | 16.54 |
| ROA %i | -8.03 | -17.53 | -18.99 | -- | -11.03 | -3.08 | 2.40 | 1.72 |
| ROIC %i | -12.24 | -29.08 | -33.51 | -- | -20.39 | -4.52 | 6.41 | 4.45 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.48 | -8.80 | -9.96 | -- | -4.45 | -0.29 | 3.55 | 3.33 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 2.24 | 2.25 |
| Current ratioi | 0.92 | 0.73 | 1.30 | -- | 1.02 | 1.03 | 1.07 | 0.88 |
| Quick ratioi | 0.54 | 0.38 | 1.01 | -- | 0.69 | 0.69 | 0.73 | 0.62 |
| Debt / assetsi | 11.58 | 12.42 | 34.81 | -- | 37.02 | 39.14 | 37.85 | 39.49 |
| LT debt / equityi | 16.80 | 20.32 | 149.55 | -- | 279.71 | 367.88 | 291.47 | 246.38 |
| Interest coveragei | -6.62 | -27.03 | -29.03 | -- | -8.05 | -0.38 | 5.35 | 5.65 |
| Revenue CAGR (3Y) %i | -- | -- | -5.05 | -- | -5.54 | -4.89 | -6.38 | -3.94 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.56 | 26.64 | 35.60 | 21.85 | 16.54 | 7.55 |
| ROA %i | 2.40 | 2.74 | 3.77 | 2.36 | 1.72 | 0.74 |
| ROIC %i | 6.41 | 6.84 | 9.03 | 5.91 | 4.45 | 2.65 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.55 | 3.68 | 4.35 | 3.19 | 3.33 | 2.39 |
| FCF / sales %i | 2.24 | 1.59 | 1.61 | 1.98 | 2.25 | 0.99 |
| Current ratioi | 1.07 | 1.05 | 1.02 | 0.86 | 0.88 | 0.85 |
| Quick ratioi | 0.73 | 0.65 | 0.63 | 0.54 | 0.62 | 0.56 |
| Debt / assetsi | 37.85 | 35.08 | 35.81 | 35.25 | 39.49 | 40.99 |
| LT debt / equityi | 291.47 | 293.03 | 294.30 | 241.62 | 246.38 | 269.63 |
| Interest coveragei | 5.35 | 6.09 | 7.51 | 5.81 | 5.65 | 3.43 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 05:39:32 · For reference only, not investment advice and not tailored to your situation.